A Randomized, Double-blind, Single-dosing, 2-way Cross-over Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 (Etanercept) 25mg With Those of Enbrel 25mg After Subcutaneous Injection in Healthy Male Volunteers
Latest Information Update: 05 Feb 2015
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis; Juvenile rheumatoid arthritis; Plaque psoriasis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors LG Life Sciences
- 22 Mar 2014 Results presented at the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 18 Mar 2014 Results presented at the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 12 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.